COMPARATIVE EFFECTS OF HIGH-DOSE ATORVASTATIN VERSUS ROSUVASTATIN ON LIPID PARAMETERS, OXIDIZED-LDL AND PCSK9 LEVELS IN ACUTE CORONARY SYNDROME
dc.contributor.author | Yalçın, Meryem Ülkü | |
dc.contributor.author | Altunkeser, Bülent Behlül | |
dc.contributor.author | Tuncez, Abdullah | |
dc.contributor.author | Öztürk, Bahadır | |
dc.contributor.author | Tezcan, Hüseyin | |
dc.contributor.author | Ateş, Muhammet S. | |
dc.contributor.author | Yılmaz, Canan | |
dc.date.accessioned | 2020-03-26T19:53:08Z | |
dc.date.available | 2020-03-26T19:53:08Z | |
dc.date.issued | 2018 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description | 86th Congress of the European-Atherosclerosis-Society (EAS) -- MAY 05-08, 2018 -- Lisbon, PORTUGAL | en_US |
dc.description.abstract | [Abstract not Available] | en_US |
dc.description.sponsorship | European Atherosclerosis Soc | en_US |
dc.identifier.doi | 10.1016/j.atherosclerosis.2018.06.719 | en_US |
dc.identifier.endpage | E228 | en_US |
dc.identifier.issn | 0021-9150 | en_US |
dc.identifier.issn | 1879-1484 | en_US |
dc.identifier.startpage | E228 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1016/j.atherosclerosis.2018.06.719 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/36412 | |
dc.identifier.volume | 275 | en_US |
dc.identifier.wos | WOS:000442512600731 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | ELSEVIER IRELAND LTD | en_US |
dc.relation.ispartof | ATHEROSCLEROSIS | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.title | COMPARATIVE EFFECTS OF HIGH-DOSE ATORVASTATIN VERSUS ROSUVASTATIN ON LIPID PARAMETERS, OXIDIZED-LDL AND PCSK9 LEVELS IN ACUTE CORONARY SYNDROME | en_US |
dc.type | Conference Object | en_US |